However, the putative mechanism by which a BNP level lower than that physiologically required exerts a pathogenic effect could be generalized to patients with cardiac diseases if, via the determination of influences of factors that suppress BNP expression (e.g., high BMI, insulin resistance, and genetic factors), we can assess whether BNP level in those patients are lower than that physiologically required. This evidence concerns the gene NPPB and heart disorder.